MDC-BIMSB

Since 2008, the Berlin Institute for Medical Systems Biology (MDC-BIMSB) has expanded the research profile of the Max Delbrück Center. The researchers at MDC-BIMSB want to understand how genes regulate the lives of cells in health and disease. This requires the Institute’s research groups to break down the traditional boundaries between disciplines such as biotechnology, computational science, biochemistry, molecular biology, and clinical research.

Further informationen on MDC-BIMSB

Article

Artsemi Yushkevic and Manqiang Lin with their prizes.
Science

Awards for the best PhDs and Postdocs of 2023

Their research is outstanding, and they’re also committed to the Max Delbrück Center and engaged in our community — Manqiang Lin and Artsemi Yushkevich wrote the best papers in 2023; Hendrik Bartolomaeus, Eleonore Adami and Ulrike Löber received the Postdoc Awards for 2023.
Simon Haas
Science

Simon Haas receives Heisenberg professorship

The German Research Foundation (DFG) will fund single-cell scientist Simon Haas in its Heisenberg program. Therefore, the Berlin Institute of Health at Charité (BIH) is establishing a Heisenberg professorship in systems hematology. After five years, the BIH will make the professorship permanent.
3 people
Institute & Campus

From Berlin to Lisbon and back

NOVA University and Max Delbrück Center are jointly establishing the NOVA Institute for Medical Systems Biology (NIMSB). Both institutions have developed a shared vision to push the boundaries of precision medicine. “Insights” spoke to the three project leads in Lisbon and Berlin.
Geschenke
Institute & Campus

A small gesture for us, a great joy for others

During three campaigns in December 2023, employees of the Max Delbrück Center took the opportunity to donate to good causes. This resulted in more than 300 gifts for children and more than 1,400 euros for the 'Kältebus' (cold bus) for homeless people in Berlin. We spoke with the organizers.
Melissa Birol
Science

Preventing the mass die-off of neurons

Melissa Birol of the Max Delbrück Center is looking to understand early stages of Alzheimer’s disease. Her focus is on the interplay between the lipid metabolism of nerve cells and the spread of tau protein. The Alzheimer Research Initiative is funding her work with 193,500 euros.
Headerbild von Lena Nitsch am BIMSB.
Institute & Campus

“I gained self-confidence in New York”

Working in Berlin-Mitte and New York – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.
Leif Ludwig
Institute & Campus

Leif Ludwig is named EMBO Young Investigator

The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.
View from the audience onto a stage where a panel discussion is taking place
Science

No precision medicine without diversity

Biomedical research is mostly geared towards white men. During the Berlin Science Week, researchers discussed how this can be changed and how questions of diversity can be better taken into account in laboratories. Didn't have time to join? We have documented the event for you as a video.
Manuel Irimia
Science

From Barcelona to Berlin

To attract renowned researchers to Berlin, Stiftung Charité is funding “Visiting Fellows” with 1.5 million euros. One of them is Manuel Irimia from Barcelona. He is coming to the Max Delbrück Center for three years to analyze gene regulation.
Human bone marrow
Press Release No. 51 Berlin

A new hub for cutting-edge cancer care

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.